Cargando…

The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer

Breast cancer stem cells (BCSC) play critical roles in the acquisition of resistance to endocrine therapy in estrogen receptor (ER)-positive (ER + ve) breast cancer (BC). The resistance results from complex alterations involving ER, growth factor receptors, NOTCH, Wnt/β-catenin, hedgehog, YAP/TAZ, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez, David, Ramkairsingh, Marc, Lin, Xiaozeng, Kapoor, Anil, Major, Pierre, Tang, Damu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678134/ https://www.ncbi.nlm.nih.gov/pubmed/31336602 http://dx.doi.org/10.3390/cancers11071028

Ejemplares similares

Effective Prediction of Prostate Cancer Recurrence through the IQGAP1 Network
por: Gu, Yan, et al.
Publicado: (2021)

An estrogen receptor (ER)‐related signature in predicting prognosis of ER‐positive breast cancer following endocrine treatment
por: Tang, Jianing, et al.
Publicado: (2019)

The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis
por: Mei, Wenjuan, et al.
Publicado: (2019)

Insights of RKIP-Derived Suppression of Prostate Cancer
por: Dong, Ying, et al.
Publicado: (2021)

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
por: Rees, Michael, et al.
Publicado: (2020)

Assessment of biochemical recurrence of prostate cancer (Review)
por: Lin, Xiaozeng, et al.
Publicado: (2019)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2015)

Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels
por: Lin, Xiaozeng, et al.
Publicado: (2022)

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
por: Groenendijk, Floris H., et al.
Publicado: (2019)

ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
por: Strillacci, Antonio, et al.
Publicado: (2022)

microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
por: Howard, Erin W., et al.
Publicado: (2018)

Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor–Positive Early Breast Cancer
por: Cheung, Yee-Ming, et al.
Publicado: (2019)

Corrigendum: Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

ER-positive breast cancer cells are poised for RET-mediated endocrine resistance
por: Horibata, Sachi, et al.
Publicado: (2018)

Construction of a Novel Multigene Panel Potently Predicting Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma
por: Lin, Xiaozeng, et al.
Publicado: (2020)

Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
por: Michmerhuizen, Anna R., et al.
Publicado: (2022)

Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
por: Shi, Liang, et al.
Publicado: (2015)

Contributions of DNA Damage to Alzheimer’s Disease
por: Lin, Xiaozeng, et al.
Publicado: (2020)

ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
por: Nath, Aritro, et al.
Publicado: (2022)

The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy
por: Xu, Jing, et al.
Publicado: (2023)

Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer
por: Pizon, Monika, et al.
Publicado: (2018)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
por: Batra, Atul, et al.
Publicado: (2020)

Microvesicles Contribute to the Bystander Effect of DNA Damage
por: Lin, Xiaozeng, et al.
Publicado: (2017)

Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells
por: Hsu, P-Y, et al.
Publicado: (2016)

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
por: Deng, Hao, et al.
Publicado: (2014)

Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel towards Prostate Cancer Relapse
por: Gu, Yan, et al.
Publicado: (2021)

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
por: Jeffreys, Sarah A., et al.
Publicado: (2020)

Role of estrogen receptor coregulators in endocrine resistant breast cancer
por: Altwegg, Kristin A., et al.
Publicado: (2021)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
por: Ojo, Diane, et al.
Publicado: (2015)

ECM1 is associated with endocrine resistance in ER(+) breast cancers
por: Lee, Tae Won, et al.
Publicado: (2022)

Review of bone health in women with estrogen receptor–positive breast cancer receiving endocrine therapy
por: Malagrinò, Matteo, et al.
Publicado: (2023)

Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
por: Long, Mengping, et al.
Publicado: (2022)

Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy
por: Kim, Tae-Jung, et al.
Publicado: (2012)

Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis
por: Gu, Yan, et al.
Publicado: (2020)

Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer
por: Papadimitropoulou, Adriana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_25fdnnq3ek9i1jg5gv0jbftbtq